Glp1 Receptor Agonists
-
{
- All
- News
-
The Rise Of Unapproved GLP-1 Products And A Growing Patient Safety Concern
GLP-1 receptor agonists have transformed diabetes and obesity treatment, but high demand fuels a risky market for unapproved and counterfeit products.
-
Struggling With Asthma? New Study Says This Common Diabetes Drug May Reduce Severe Attacks By 40 Per Cent
The study has found that people with asthma who were prescribed semaglutide appeared to have nearly 40 per cent fewer asthma attacks compared to similar people taking another type of diabetes medicine.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
The Rise Of Unapproved GLP-1 Products And A Growing Patient Safety Concern
GLP-1 receptor agonists have transformed diabetes and obesity treatment, but high demand fuels a risky market for unapproved and counterfeit products.
-
Struggling With Asthma? New Study Says This Common Diabetes Drug May Reduce Severe Attacks By 40 Per Cent
The study has found that people with asthma who were prescribed semaglutide appeared to have nearly 40 per cent fewer asthma attacks compared to similar people taking another type of diabetes medicine.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
